AFX.DE Live signaler | Maksimer profitt med Getagraph.com

Live Chart Being Loaded With Signals

Commentary (31 mai 2024 @ 17:35):

Stats
Dagens volum	412 286
Gjennomsnittsvolum	137 574
Markedsverdi	7.57B
EPS	€0 ( 2024-05-07 )
Last Dividend	€1.100 ( 2023-03-23 )
Next Dividend	€0 ( N/A )
P/E	28.89
ATR14	€0.128 (0.15%)

Volum Korrelasjon

Lang: -0.02 (neutral)

Kort: -0.70 (moderate negative)

Signal:(44.716) Neutral

Carl Zeiss Meditec AG Korrelasjon

10 Mest positive korrelasjoner

10 Mest negative korrelasjoner

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Carl Zeiss Meditec AG Korrelasjon - Valuta/Råvare

-0.13
( neutral )

-0.19
( neutral )

0.00
( neutral )

-0.40
( neutral )

0.13
( neutral )

0.62
( weak )

Carl Zeiss Meditec AG Økonomi

Annual	2023
Omsetning:	€2.09B
Bruttogevinst:	€1.21B (57.71 %)
EPS:	€3.25

FY	2023
Omsetning:	€2.09B
Bruttogevinst:	€1.21B (57.71 %)
EPS:	€3.25

FY	2022
Omsetning:	€1.90B
Bruttogevinst:	€1.13B (59.26 %)
EPS:	€3.29

FY	2021
Omsetning:	€1.65B
Bruttogevinst:	€967.21M (58.73 %)
EPS:	€2.64

Financial Reports:

No articles found.

Carl Zeiss Meditec AG Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
€0 (N/A)	€0 (N/A)	€1.100 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)	€0 (N/A)

Carl Zeiss Meditec AG Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 9.45 - good (94.53%) | Divividend Growth Potential Score: 6.71 - Stable (34.16%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	€0.117	2006-03-13
Last Dividend	€1.100	2023-03-23
Next Dividend	€0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	19	--
Total Paid Out	€8.36	--
Avg. Dividend % Per Year	0.00%	--
Score	3.11	--
Div. Sustainability Score	9.45
Div.Growth Potential Score	6.71
Div. Directional Score	8.08	--

Next Divdend (Est)
(2024-12-17)

€0 Estimate 0.00 %

Dividend Stability

0.06 Very Bad

Dividend Score

3.11

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for XETRA

Symbol	Title	Last dividend	Frequency	Yearly Dividend
LOM.DE	Ex Dividend Knight	2023-08-31	Quarterly	0.00%
CEK.DE	No Dividend Player	2023-11-06	Sporadic	0.00%
PAH3.DE	Ex Dividend Knight	2023-07-03	Annually	0.00%
ENI.F	Ex Dividend Knight	2023-11-20	Semi-Annually	0.00%
TA1.DE	Ex Dividend Knight	2023-06-12	Annually	0.00%
HCL.DE	Ex Dividend Junior	2023-08-23	Quarterly	0.00%
AEND.DE	Ex Dividend Junior	2023-08-29	Semi-Annually	0.00%
BWB.DE	Ex Dividend Junior	2023-07-07	Sporadic	0.00%
NVD.DE	Ex Dividend Knight	2023-09-06	Quarterly	0.00%
DWS.DE	Ex Dividend Knight	2023-06-16	Annually	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.103	1.500	7.94	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0895	1.200	7.02	8.42	[0 - 0.3]
returnOnEquityTTM	0.124	1.500	9.73	10.00	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	3.51	0.800	10.00	8.00	[1 - 3]
quickRatioTTM	0.761	0.800	-0.232	-0.185	[0.8 - 2.5]
cashRatioTTM	0.0302	1.500	-0.943	-1.415	[0.2 - 2]
debtRatioTTM	0.0486	-1.500	9.19	-10.00	[0 - 0.6]
interestCoverageTTM	22.96	1.000	2.61	2.61	[3 - 30]
operatingCashFlowPerShareTTM	2.95	2.00	9.02	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.361	2.00	9.32	10.00	[0 - 20]
debtEquityRatioTTM	0.0678	-1.500	9.73	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.645	1.000	2.58	2.58	[0.2 - 0.8]
operatingProfitMarginTTM	0.166	1.000	8.67	8.67	[0.1 - 0.6]
cashFlowToDebtRatioTTM	1.854	1.000	0.811	0.811	[0.2 - 2]
assetTurnoverTTM	0.869	0.800	7.54	6.03	[0.5 - 2]
Total Score				9.45

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	28.96	1.000	7.18	0	[1 - 100]
returnOnEquityTTM	0.124	2.50	9.83	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.361	2.00	9.55	10.00	[0 - 30]
dividendYielPercentageTTM	1.299	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.95	2.00	9.02	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	2.88	1.500	10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.104	1.000	9.91	0	[0.1 - 0.5]
Total Score				6.71

Carl Zeiss Meditec AG Options Data

Calls

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Puts

Contract Name	Last Trade Date (EDT)	Strike	Last Price	Bid	Ask	Change	% Change	Volume	Open Interest	Implied Volatility	Strike Date
No data available

Carl Zeiss Meditec AG

Carl Zeiss Meditec AG operates as a medical technology company in Germany, rest of Europe, the United States, Asia, and internationally. It operates in two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers products and solutions for the diagnosis and treatment of eye diseases; and systems and consumables for cataract, retinal, and refractive surgeries. It serves practicing ophthalmologists and optometrists, as well as physicians and surgeons in hospitals and outpatient surgery centers. The Microsurgery segment offers visualization solutions for invasive surgical treatments; and solutions in the area of ear, nose and throat, plastic and reconstructive, dental and spinal surgeries. It serves physicians in various fields and hospitals. The company was founded in 1846 and is headquartered in Jena, Germany. Carl Zeiss Meditec AG is a subsidiary of Carl Zeiss AG.